Trade

Vivo Bio Tech share price

Balanced risk
  • 40%Low risk
  • 40%Moderate risk
  • 40%Balanced risk
  • 40%High risk
  • 40%Extreme risk
  • 28.50(-2.63%)
    December 12, 2025 09:35:08 AM IST
    • NSE
    • BSE
  • Vol : 0.85 K (NSE + BSE)
    Last 20 day avg : 23.50 K

Vivo Bio Tech is trading -2.63% lower at Rs 28.50 as compared to its last closing price. Vivo Bio Tech has been trading in the price range of 29.84 & 28.50. Vivo Bio Tech has given -21.17% in this year & -2.89% in the last 5 days. The company posted a net profit of 0.87 Crores in its last quarter.Listed peers of Vivo Bio Tech include Torrent Pharmaceuticals (0.73%), Divi's Laboratories (0.85%), Cipla (0.27%).The Mutual Fund holding in Vivo Bio Tech was at -% in . The MF holding has - from the last quarter. The FII holding in Vivo Bio Tech was at -% in . The FII holding has - from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Dec 12, 2025, 04:36 AM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    1.06
    Medium volatility
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    0.60
    Lower than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    11.42
    Lower than historical values
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    0.25
    Indicates undervaluation
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    -
Price range
Day Range
Lowest
28.50
Highest
29.84
52 week range
Lowest
25.21
Highest
56.90
Vivo Bio Tech Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Torrent Pharmaceuticals
Bullish
3,829.000.731,29,527.6266.6416.920.8417.62
Divi's Laboratories
Bullish
6,487.050.851,72,208.1278.2711.470.460.01
Cipla
Neutral
1,516.200.271,22,482.3823.333.940.850.81
Sun Pharmaceutical Industries
Bullish
1,804.00-0.164,32,757.6237.946.040.880.50
Dr Reddy's Laboratories
Bullish
1,272.50-0.041,06,200.5718.803.170.632.34
Vivo Bio Tech Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2025-11-14Quarterly Results
2025-08-12Quarterly Results
2025-05-19Audited Results
2025-01-09Quarterly Results
2024-11-21Employees Stock Option Plan
About the company Vivo Bio Tech
  • IndustryBiotechnology & Drugs
  • ISININE380K01017
  • BSE Code511509
  • NSE Code
Vivo Bio Tech Limited is an India-based company, which is a comprehensive preclinical clinical research organization (CRO) serving pharmaceutical and biotech firms. It operates in the biotechnology segment. It provides integrated discovery, development & regulatory services to pharmaceutical, agrochemical, industrial chemical, vaccines, nutraceutical & medical device companies. The Company's services include in-Vivo and in-Vitro toxicity studies, pharmacological investigations, pharmacokinetic, toxicokinetic studies, genotoxicity screening and analytical services. It screens and assesses molecules for diverse pharmacological properties. In oncology, it designs syngeneic/xenograft models for anti-cancer agent evaluation. It customizes in-Vivo DMPK studies for rodent and non-rodent models to profile drug candidates. It provides both regulatory and non-regulatory IND-enabling preclinical development services.
  • Management Info
  • Kompella Sri KalyanChief Financial Officer, Additional Whole-time Director
  • Vaishnavi AyinampudiCompliance Officer, Company Secretary
  • M. Kalyan RamWhole Time Director
Vivo Bio Tech Share Price FAQs

Vivo Bio Tech is trading at 28.50 as on Fri Dec 12 2025 04:05:08. This is -2.63% lower as compared to its previous closing price of 29.27.

The market capitalization of Vivo Bio Tech is 60.80 Cr as on Fri Dec 12 2025 04:05:08.

The 52 wk high for Vivo Bio Tech is 56.90 whereas the 52 wk low is 25.21

Vivo Bio Tech can be analyzed on the following key metrics -

  • TTM P/E: 15.56
  • Sector P/E: -
  • Dividend Yield: 0.00%
  • D/E ratio: 0.58

Vivo Bio Tech reported a net profit of 7.28 Cr in 2025.